Donoghue Forlines’s Medtronic MDT Stock Holding History

Donoghue Forlines’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Buy	21,565 +2,857	+15%	+$230K	0.44%	89
2026 Q1	$1.62M	Buy	18,708 +3,954	+27%	+$379K	0.45%	90
2025 Q4	$1.42M	Sell	14,754 -1,357	-8%	-$132K	0.44%	99
2025 Q3	$1.53M	Sell	16,111 -620	-4%	-$57K	0.47%	73
2025 Q2	$1.46M	Buy	16,731 +826	+5%	+$70K	0.42%	83
2025 Q1	$1.43M	Sell	15,905 -2,923	-16%	-$262K	0.45%	95
2024 Q4	$1.5M	Buy	+18,828	New	+$1.63M	0.5%	72
2019 Q4	–	Sell	-22,115	Closed	-$2.4M	–	184
2019 Q3	$2.4M	Buy	+22,115	New	+$2.31M	0.34%	98

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Donoghue Forlines's MDT Position: Q2 2026 in Review

Donoghue Forlines increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $230K and bringing the position to 21,565 shares worth $1.69M. The position accounts for 0.44% of the portfolio, ranked #89.

Donoghue Forlines first reported a position in MDT in Q3 2019 and has held it in 8 quarters since. The position peaked at $2.4M in Q3 2019. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Donoghue Forlines held 21,565 shares of Medtronic worth $1.69M as of Q2 2026.
Donoghue Forlines bought 2,857 Medtronic shares in Q2 2026, an estimated $230K.
Medtronic made up 0.44% of Donoghue Forlines's portfolio in Q2 2026, its #89 holding.
Donoghue Forlines first reported a position in Medtronic in Q3 2019 and has held it in 8 quarters since.
Donoghue Forlines's Medtronic position peaked at $2.4M in Q3 2019.
2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.